Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.82 Billion USD | 11.87% |
| 2022 | 2.52 Billion USD | 7.05% |
| 2021 | 2.35 Billion USD | 23.94% |
| 2020 | 1.9 Billion USD | 35.91% |
| 2019 | 1.4 Billion USD | 904.03% |
| 2018 | 139.45 Million USD | 15.81% |
| 2017 | 120.4 Million USD | -58.32% |
| 2016 | 288.91 Million USD | 97.56% |
| 2015 | 146.23 Million USD | 323.52% |
| 2014 | -65.42 Million USD | -155.14% |
| 2013 | 118.64 Million USD | 22.3% |
| 2012 | 97.01 Million USD | 34.19% |
| 2011 | 72.29 Million USD | 1.22% |
| 2010 | 71.41 Million USD | -3.17% |
| 2009 | 73.75 Million USD | 7.14% |
| 2008 | 68.83 Million USD | 136.76% |
| 2007 | 29.07 Million USD | 1.67% |
| 2006 | 28.59 Million USD | 3.59% |
| 2005 | 27.6 Million USD | -6.78% |
| 2004 | 29.61 Million USD | 10.53% |
| 2003 | 26.79 Million USD | -7.96% |
| 2002 | 29.11 Million USD | -9.45% |
| 2001 | 32.14 Million USD | -11.41% |
| 2000 | 36.28 Million USD | 597.84% |
| 1999 | 5.2 Million USD | -20.0% |
| 1998 | 6.5 Million USD | 16.07% |
| 1997 | 5.6 Million USD | -39.13% |
| 1996 | 9.2 Million USD | -70.61% |
| 1995 | 31.3 Million USD | -47.48% |
| 1994 | 59.6 Million USD | -6.14% |
| 1993 | 63.5 Million USD | 17.16% |
| 1992 | 54.2 Million USD | 46.09% |
| 1991 | 37.1 Million USD | 18.15% |
| 1990 | 31.4 Million USD | 27.13% |
| 1989 | 24.7 Million USD | -10.18% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.84 Billion USD | 0.88% |
| 2024 Q2 | 2.86 Billion USD | 0.44% |
| 2023 Q3 | 2.51 Billion USD | -1.37% |
| 2023 Q1 | 2.53 Billion USD | 0.54% |
| 2023 Q2 | 2.54 Billion USD | 0.42% |
| 2023 FY | 2.82 Billion USD | 11.87% |
| 2023 Q4 | 2.82 Billion USD | 12.34% |
| 2022 Q4 | 2.52 Billion USD | 2.52% |
| 2022 Q3 | 2.46 Billion USD | 0.72% |
| 2022 Q1 | 2.38 Billion USD | 1.08% |
| 2022 FY | 2.52 Billion USD | 7.05% |
| 2022 Q2 | 2.44 Billion USD | 2.56% |
| 2021 FY | 2.35 Billion USD | 23.94% |
| 2021 Q1 | 1.92 Billion USD | 1.28% |
| 2021 Q2 | 2.01 Billion USD | 4.6% |
| 2021 Q3 | 2.24 Billion USD | 11.18% |
| 2021 Q4 | 2.35 Billion USD | 5.22% |
| 2020 Q3 | 1.47 Billion USD | 2.38% |
| 2020 Q2 | 1.44 Billion USD | 2.53% |
| 2020 Q1 | 1.4 Billion USD | 0.45% |
| 2020 FY | 1.9 Billion USD | 35.91% |
| 2020 Q4 | 1.9 Billion USD | 28.89% |
| 2019 FY | 1.4 Billion USD | 904.03% |
| 2019 Q4 | 1.4 Billion USD | 1.55% |
| 2019 Q2 | 1.06 Billion USD | 33.88% |
| 2019 Q1 | 797.92 Million USD | 472.19% |
| 2019 Q3 | 1.37 Billion USD | 29.06% |
| 2018 Q3 | 762.12 Million USD | 2.29% |
| 2018 Q1 | 743.24 Million USD | 517.27% |
| 2018 FY | 139.45 Million USD | 15.81% |
| 2018 Q4 | 139.45 Million USD | -81.7% |
| 2018 Q2 | 745.08 Million USD | 0.25% |
| 2017 Q2 | 308.76 Million USD | 6.24% |
| 2017 Q1 | 290.62 Million USD | 0.59% |
| 2017 Q4 | 120.4 Million USD | -83.6% |
| 2017 FY | 120.4 Million USD | -58.32% |
| 2017 Q3 | 734.23 Million USD | 137.8% |
| 2016 Q3 | 285.05 Million USD | 0.97% |
| 2016 FY | 288.91 Million USD | 97.56% |
| 2016 Q4 | 288.91 Million USD | 1.36% |
| 2016 Q2 | 282.31 Million USD | 91.63% |
| 2016 Q1 | 147.32 Million USD | 0.74% |
| 2015 Q4 | 146.23 Million USD | 4.56% |
| 2015 Q1 | 128.58 Million USD | 296.53% |
| 2015 Q3 | 139.85 Million USD | 1.83% |
| 2015 Q2 | 137.34 Million USD | 6.81% |
| 2015 FY | 146.23 Million USD | 323.52% |
| 2014 Q4 | -65.42 Million USD | -150.78% |
| 2014 Q3 | 128.83 Million USD | -0.17% |
| 2014 FY | -65.42 Million USD | -155.14% |
| 2014 Q1 | 119.33 Million USD | 0.58% |
| 2014 Q2 | 129.04 Million USD | 8.14% |
| 2013 Q1 | 97.31 Million USD | 0.31% |
| 2013 FY | 118.64 Million USD | 22.3% |
| 2013 Q2 | 104.65 Million USD | 7.54% |
| 2013 Q3 | 111.63 Million USD | 6.67% |
| 2013 Q4 | 118.64 Million USD | 6.28% |
| 2012 Q1 | 80.39 Million USD | 0.0% |
| 2012 Q2 | 81.44 Million USD | 1.31% |
| 2012 Q3 | 84.89 Million USD | 4.23% |
| 2012 Q4 | 97.01 Million USD | 14.27% |
| 2012 FY | 97.01 Million USD | 34.19% |
| 2011 Q1 | 72.29 Million USD | -1.1% |
| 2011 Q2 | 71.6 Million USD | -0.95% |
| 2011 Q3 | 72.56 Million USD | 1.34% |
| 2011 FY | 72.29 Million USD | 1.22% |
| 2010 Q1 | 71.41 Million USD | -0.12% |
| 2010 FY | 71.41 Million USD | -3.17% |
| 2010 Q4 | 73.09 Million USD | 0.65% |
| 2010 Q3 | 72.62 Million USD | 1.49% |
| 2010 Q2 | 71.56 Million USD | 0.2% |
| 2009 Q4 | 71.5 Million USD | -0.19% |
| 2009 FY | 73.75 Million USD | 7.14% |
| 2009 Q1 | 73.75 Million USD | -2.02% |
| 2009 Q2 | 71.45 Million USD | -3.12% |
| 2009 Q3 | 71.64 Million USD | 0.26% |
| 2008 Q2 | 75.6 Million USD | 9.83% |
| 2008 FY | 68.83 Million USD | 136.76% |
| 2008 Q1 | 68.83 Million USD | -2.3% |
| 2008 Q3 | 76.02 Million USD | 0.54% |
| 2008 Q4 | 75.27 Million USD | -0.98% |
| 2007 FY | 29.07 Million USD | 1.67% |
| 2007 Q1 | 29.07 Million USD | 0.64% |
| 2007 Q2 | 29.91 Million USD | 2.87% |
| 2007 Q4 | 70.45 Million USD | -0.49% |
| 2007 Q3 | 70.8 Million USD | 136.71% |
| 2006 Q2 | 28.7 Million USD | 0.38% |
| 2006 Q4 | 28.89 Million USD | 2.85% |
| 2006 Q1 | 28.59 Million USD | -2.15% |
| 2006 FY | 28.59 Million USD | 3.59% |
| 2006 Q3 | 28.09 Million USD | -2.14% |
| 2005 Q2 | 28.96 Million USD | 4.92% |
| 2005 FY | 27.6 Million USD | -6.78% |
| 2005 Q1 | 27.6 Million USD | 0.71% |
| 2005 Q4 | 29.22 Million USD | 0.47% |
| 2005 Q3 | 29.09 Million USD | 0.43% |
| 2004 Q2 | 29.02 Million USD | -1.99% |
| 2004 Q3 | 27.36 Million USD | -5.73% |
| 2004 Q4 | 27.41 Million USD | 0.18% |
| 2004 FY | 29.61 Million USD | 10.53% |
| 2004 Q1 | 29.61 Million USD | -10.66% |
| 2003 Q4 | 33.15 Million USD | -5.46% |
| 2003 Q3 | 35.06 Million USD | -4.74% |
| 2003 FY | 26.79 Million USD | -7.96% |
| 2003 Q1 | 26.79 Million USD | -3.9% |
| 2003 Q2 | 36.8 Million USD | 37.37% |
| 2002 Q4 | 27.88 Million USD | -1.85% |
| 2002 Q3 | 28.4 Million USD | -6.16% |
| 2002 Q2 | 30.27 Million USD | 3.98% |
| 2002 Q1 | 29.11 Million USD | 1.38% |
| 2002 FY | 29.11 Million USD | -9.45% |
| 2001 Q4 | 28.71 Million USD | -3.23% |
| 2001 Q3 | 29.67 Million USD | -3.26% |
| 2001 Q2 | 30.67 Million USD | -4.59% |
| 2001 Q1 | 32.14 Million USD | -3.84% |
| 2001 FY | 32.14 Million USD | -11.41% |
| 2000 Q3 | 34.77 Million USD | -2.34% |
| 2000 FY | 36.28 Million USD | 597.84% |
| 2000 Q2 | 35.6 Million USD | -1.88% |
| 2000 Q4 | 33.43 Million USD | -3.86% |
| 2000 Q1 | 36.28 Million USD | 224.0% |
| 1999 Q4 | 11.2 Million USD | -13.85% |
| 1999 Q2 | 13.8 Million USD | 165.38% |
| 1999 Q1 | 5.2 Million USD | -8.77% |
| 1999 FY | 5.2 Million USD | -20.0% |
| 1999 Q3 | 13 Million USD | -5.8% |
| 1998 FY | 6.5 Million USD | 16.07% |
| 1998 Q1 | 6.5 Million USD | -2.99% |
| 1998 Q2 | 6.3 Million USD | -3.08% |
| 1998 Q3 | 6.1 Million USD | -3.17% |
| 1998 Q4 | 5.7 Million USD | -6.56% |
| 1997 Q1 | 5.6 Million USD | -1.75% |
| 1997 Q4 | 6.7 Million USD | 36.73% |
| 1997 Q3 | 4.9 Million USD | -7.55% |
| 1997 Q2 | 5.3 Million USD | -5.36% |
| 1997 FY | 5.6 Million USD | -39.13% |
| 1996 FY | 9.2 Million USD | -70.61% |
| 1996 Q2 | 5.2 Million USD | -43.48% |
| 1996 Q3 | 5.2 Million USD | 0.0% |
| 1996 Q4 | 5.7 Million USD | 9.62% |
| 1996 Q1 | 9.2 Million USD | -49.17% |
| 1995 Q1 | 31.3 Million USD | -23.84% |
| 1995 Q2 | 22.1 Million USD | -29.39% |
| 1995 Q4 | 18.1 Million USD | -17.73% |
| 1995 Q3 | 22 Million USD | -0.45% |
| 1995 FY | 31.3 Million USD | -47.48% |
| 1994 FY | 59.6 Million USD | -6.14% |
| 1994 Q3 | 45.2 Million USD | -14.23% |
| 1994 Q4 | 41.1 Million USD | -9.07% |
| 1994 Q1 | 59.6 Million USD | 25.74% |
| 1994 Q2 | 52.7 Million USD | -11.58% |
| 1993 Q1 | 63.5 Million USD | 7.63% |
| 1993 Q2 | 56.2 Million USD | -11.5% |
| 1993 Q3 | 51.4 Million USD | -8.54% |
| 1993 FY | 63.5 Million USD | 17.16% |
| 1993 Q4 | 47.4 Million USD | -7.78% |
| 1992 Q3 | 58.4 Million USD | -2.01% |
| 1992 FY | 54.2 Million USD | 46.09% |
| 1992 Q4 | 59 Million USD | 1.03% |
| 1992 Q1 | 54.2 Million USD | 0.0% |
| 1992 Q2 | 59.6 Million USD | 9.96% |
| 1991 Q1 | 37.1 Million USD | -1.85% |
| 1991 FY | 37.1 Million USD | 18.15% |
| 1991 Q2 | 58.7 Million USD | 58.22% |
| 1991 Q3 | 56.8 Million USD | -3.24% |
| 1991 Q4 | 54.2 Million USD | -4.58% |
| 1990 FY | 31.4 Million USD | 27.13% |
| 1990 Q1 | 31.4 Million USD | 0.0% |
| 1990 Q2 | 40.7 Million USD | 29.62% |
| 1990 Q4 | 37.8 Million USD | -3.32% |
| 1990 Q3 | 39.1 Million USD | -3.93% |
| 1989 Q1 | 24.7 Million USD | 0.0% |
| 1989 FY | 24.7 Million USD | -10.18% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -1465.907% |
| AngioDynamics, Inc. | 317.67 Million USD | -789.099% |
| AtriCure, Inc. | 613.93 Million USD | -360.053% |
| Avinger, Inc. | 13.77 Million USD | -20411.336% |
| Azenta, Inc. | 2.88 Billion USD | 2.125% |
| BioLife Solutions, Inc. | 412.71 Million USD | -584.351% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 75.775% |
| Daxor Corporation | 34.86 Million USD | -8000.03% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -9666.965% |
| Femasys Inc. | 27.75 Million USD | -10075.922% |
| GlucoTrack, Inc. | 4.9 Million USD | -57482.283% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -1956.121% |
| Hologic, Inc. | 9.15 Billion USD | 69.152% |
| ICU Medical, Inc. | 4.37 Billion USD | 35.493% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 81.709% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -9823.804% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -714.472% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -45317.577% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -45317.577% |
| Masimo Corporation | 3.04 Billion USD | 7.138% |
| Microbot Medical Inc. | 8.32 Million USD | -33818.71% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -1542.909% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | -21.467% |
| Nephros, Inc. | 11.86 Million USD | -23712.587% |
| NovoCure Limited | 1.14 Billion USD | -146.43% |
| NEXGEL, Inc. | 9.95 Million USD | -28271.783% |
| NEXGEL, Inc. | 9.95 Million USD | -28271.783% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -963.941% |
| OraSure Technologies, Inc. | 482.84 Million USD | -484.952% |
| Pro-Dex, Inc. | 54.21 Million USD | -5110.129% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -4545.107% |
| Predictive Oncology Inc. | 14.41 Million USD | -19490.499% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -16600.066% |
| QuidelOrtho Corporation | 8.56 Billion USD | 67.016% |
| Sanara MedTech Inc. | 73.87 Million USD | -3723.429% |
| STAAR Surgical Company | 488.69 Million USD | -477.953% |
| Sharps Technology, Inc. | 11.78 Million USD | -23857.476% |
| Utah Medical Products, Inc. | 135.45 Million USD | -1985.082% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 61.677% |
| Jin Medical International Ltd. | 32.9 Million USD | -8483.936% |